comparemela.com

Latest Breaking News On - Davidf hale - Page 1 : comparemela.com

Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated at StockNews com

Research analysts at StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a research report issued to clients and investors on Wednesday. The brokerage set a “sell” rating on the stock. A number of other research analysts have also recently weighed in on the stock. HC Wainwright cut shares of Oncternal […]

StockNews com Begins Coverage on Oncternal Therapeutics (NASDAQ:ONCT)

StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a research note published on Tuesday morning. The brokerage issued a sell rating on the stock. A number of other analysts also recently issued reports on ONCT. HC Wainwright downgraded shares of Oncternal Therapeutics from a buy rating to a neutral rating […]

Oncternal Therapeutics (NASDAQ:ONCT) Now Covered by StockNews com

StockNews.com began coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the stock. A number of other brokerages also recently weighed in on ONCT. Oppenheimer downgraded Oncternal Therapeutics from an outperform rating to a market perform rating […]

Oncternal Therapeutics (NASDAQ:ONCT) Earns Sell Rating from Analysts at StockNews com

StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a report published on Monday. The firm issued a sell rating on the stock. A number of other brokerages have also recently issued reports on ONCT. Oppenheimer cut shares of Oncternal Therapeutics from an outperform rating to a market perform rating in […]

Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated at StockNews com

Research analysts at StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a report released on Monday. The firm set a “sell” rating on the stock. ONCT has been the subject of several other reports. Brookline Capital Acquisition reaffirmed a “hold” rating on shares of Oncternal Therapeutics in a research report […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.